Nilotinib treatment-associated accelerated atherosclerosis: When is the risk justified?

Research output: Contribution to journalLetter

21 Scopus citations
Original languageEnglish (US)
Pages (from-to)1939-1940
Number of pages2
JournalLeukemia
Volume27
Issue number9
DOIs
StatePublished - Sep 1 2013

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this